Nerlynx
NDC 70437-240, neratinib, tablet, from Puma Biotechnology, Inc..
- Product NDC
- 70437-240
- Status
- Listed
- Labeler
- Puma Biotechnology, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208051
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70437-240 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NERATINIB MALEATE ANHYDROUS40 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70437-240-18 | 70437024018 | 1 BOTTLE in 1 BOX (70437-240-18) / 180 TABLET in 1 BOTTLE |
| 70437-240-26 | 70437024026 | 1 BOTTLE in 1 BOX (70437-240-26) / 126 TABLET in 1 BOTTLE |
| 70437-240-33 | 70437024033 | 1 BOTTLE in 1 BOX (70437-240-33) / 133 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d1e41dcf-e82a-47c2-a0ad-6c6eef621834
Use it
Look up 70437-240 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70437-240 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70437-240. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.